Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant. [electronic resource]
Producer: 20050930Description: 8170-6 p. digitalISSN:- 1078-0432
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Combined Modality Therapy
- Disease-Free Survival
- Female
- Humans
- Middle Aged
- Multiple Myeloma -- therapy
- Prednisone -- administration & dosage
- Stem Cell Transplantation
- Survival Rate
- Thalidomide -- administration & dosage
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.